John S. Stehlin

5.4k total citations · 3 hit papers
86 papers, 4.4k citations indexed

About

John S. Stehlin is a scholar working on Oncology, Molecular Biology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, John S. Stehlin has authored 86 papers receiving a total of 4.4k indexed citations (citations by other indexed papers that have themselves been cited), including 50 papers in Oncology, 39 papers in Molecular Biology and 14 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in John S. Stehlin's work include Cancer therapeutics and mechanisms (22 papers), Cutaneous Melanoma Detection and Management (14 papers) and CAR-T cell therapy research (8 papers). John S. Stehlin is often cited by papers focused on Cancer therapeutics and mechanisms (22 papers), Cutaneous Melanoma Detection and Management (14 papers) and CAR-T cell therapy research (8 papers). John S. Stehlin collaborates with scholars based in United States, Sweden and Kenya. John S. Stehlin's co-authors include Beppino C. Giovanella, Leo J. Williams, George Klein, J. L. Smith, M Potmĕsil, Alton C. Morgan, R. Lee Clark, Allan W. Nicholas, Robert Silber and Monroe E. Wall and has published in prestigious journals such as Science, Proceedings of the National Academy of Sciences and JAMA.

In The Last Decade

John S. Stehlin

85 papers receiving 3.8k citations

Hit Papers

DNA Topoisomerase I—Targeted Chemotherapy of Human Colon ... 1974 2026 1991 2008 1989 1975 1974 100 200 300 400 500

Peers

John S. Stehlin
Comparison fields: 5 of 128
  • Oncology 2.4k
  • Molecular Biology 2.0k
  • Immunology 559
  • Pulmonary and Respiratory Medicine 435
  • Epidemiology 423
Replace S. E. Salmon with:
S. E. Salmon United States
W. Wilmanns Germany
V R Zurawski United States
P. Schlag Germany
D L Morton United States
Harvey D. Preisler United States
Serge Jothy Canada
Giora M. Mavligit United States
E. M. Hersh United States
Albert Deisseroth United States
S. E. Salmon United States View profile →
Citations per field, relative to John S. Stehlin
John S. Stehlin · 1×
Citations per year, relative to John S. Stehlin
John S. Stehlin · 1×

Countries citing papers authored by John S. Stehlin

Since Specialization
Citations

This map shows the geographic impact of John S. Stehlin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John S. Stehlin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John S. Stehlin more than expected).

Fields of papers citing papers by John S. Stehlin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by John S. Stehlin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John S. Stehlin. The network helps show where John S. Stehlin may publish in the future.

Co-authorship network of co-authors of John S. Stehlin

This figure shows the co-authorship network connecting the top 25 collaborators of John S. Stehlin. A scholar is included among the top collaborators of John S. Stehlin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with John S. Stehlin. John S. Stehlin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
# Work Indexed citations
1 17
2 43
3 2
4 9
5 61
6
Pharmacodynamics/pharmacokinetics of intragastric camptothecin analogs in a human-cancer xenograft model
4
7
Studies of time/dose intensity in treatment of human cancer xenografts with camptothecin analogues
6
8 32
9
Complete inhibition of growth followed by death of human malignant melanoma cells in vitro and regression of human melanoma xenografts in immunodeficient mice induced by camptothecins.
77
10 50
11
Complete growth inhibition of human cancer xenografts in nude mice by treatment with 20-(S)-camptothecin.
164
12 17
13 98
14 4
15 6
16 67
17 19
18 19
19
Regression of human tumors established in nude mice after continuous infusion of thymidine.
29
20 15

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026